An official website of the United States government

Here's how you know

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

COVID-19

Expand for resources

PAR-22-200 - Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 2

Active NOSIs

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)
Notice of Special Interest (NOSI): HEAL Initiative: Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose	NOT-DA-23-010	NIDA	Sep 28, 2022	Sep 2, 2025	UG3/UH3

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)
Notice of Special interest (NOSI): Medications Development for Stimulant Use Disorders	NOT-DA-22-049	NIDA	Dec 22, 2021	Sep 2, 2022	UG3/UH3